Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use

PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use

US Patent 12454565 · Granted Oct 28, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use2025
Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use2025
Ultra-long acting insulin-Fc fusion protein and methods of use2025
Ultra-long acting insulin-Fc fusion protein and methods of use2025
Ultra-long acting insulin-Fc fusion protein2025
Ultra-long acting insulin-Fc fusion protein2025
Ultra-long acting insulin-Fc fusion proteins and methods of use2024
Ultra-long acting insulin-Fc fusion proteins and methods of use2024
Ultra-long acting insulin-Fc fusion protein and methods of use2023
Ultra-long acting insulin-Fc fusion protein and methods of use2023
Ultra-long acting insulin-Fc fusion proteins and methods of use2023
Ultra-long acting insulin-Fc fusion proteins and methods of use2023